Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

8 results about "Polymerase Gene" patented technology

Polymerase Genes encode enzymes (Polymerases) that catalyze polymerization reactions, especially of nucleotides to polynucleotides. (NCI)

Genetically engineered bacterium for producing polydeoxyribonucleotide as well as construction method and application of genetically engineered bacterium

The invention provides a genetically engineered bacterium for producing polydeoxyribonucleotide as well as a construction method and application of the genetically engineered bacterium. The genetically engineered bacterium comprises kluyveromyces marxianus for expressing a salmon DNA polymerase I gene. According to the invention, the edible probiotic Kluyveromyces marxianus is transformed through genetic engineering, efficient, safe and controllable production of PDRN is realized, the biological activity of PDRN is equivalent to that of PDRN from a natural source, and large-scale production and application of PDRN are facilitated.
Owner:SHANGHAI JIAXIN BIOTECHNOLOGY CO LTD

PLS DNA polymerase constructed by DNA polymerase-DNA binding protein and application thereof in DNA information storage

A kind of PLS DNA polymerase constructed by DNA polymerase-DNA binding protein and its application in DNA information storage belong to the technical field of biochemistry and molecular biology.The present application connects Sso7d DNA binding protein to the C-terminal of 9°N DNA polymerase by flexible short peptide to construct fusion protein PLS DNA polymerase.The codon-optimized PLS DNA polymerase gene is chemically synthesized, and high-purity PLS DNA polymerase is prepared by purification;the enzymatic properties of the PLS DNA polymerase and its application effects in in vitro DNA information storage addressing and in vivo DNA information storage assembling DNA active block are systematically evaluated.The results show that after fusing DNA binding protein, the performance of PLS DNA polymerase such as continuous synthesis ability, fidelity and PCR efficiency is significantly improved, and specific files can be recovered from mixed file pool to realize random addressing.
Owner:JILIN UNIVERSITY

Small-molecule RNA for alleviating lignification of loquat fruit and application thereof

This invention belongs to the field of plant molecular biology, specifically relating to a small RNA molecule that alleviates lignification of loquat fruit and its application. The small RNA molecule is from loquat. Eja-MIR164 Its nucleotide sequence is shown in SEQ ID NO. 6. After processing within the plant, it forms a functional mature form. This invention experimentally confirms that loquat fruit contains… Eja-MIR164 The expression level of Eja-miR164 was negatively correlated with lignin content; transient interference or stable transformation using STTM technology reduced Eja-miR164 content, targeting its genes NAC transcription factor and lignin polymerase gene. EjLAC7 Increased expression levels in all samples led to a significant increase in lignin content. This invention utilizes small RNA molecules. Eja- MIR164 It can be used to breed new loquat varieties with reduced lignification, improve fruit texture and quality, and enhance post-harvest storage performance, and has potential application value in loquat genetic improvement and molecular breeding.
Owner:ZHEJIANG UNIV

Methods of treatment for POLG mutation disorders

PCT designated stageWO2026136985A1Nervous disorderOrganic chemistryMitochondrial depletionPsychiatry
Provided are methods of treating a Primary Mitochondrial Disorder (PMD) or Mitochondrial DNA Depletion Syndrome (MDDS) in a subject in need thereof comprising: administering a therapeutically effective amount of a compound listed in Table 1, Table 2, Table 3, Table 4, or Table 5. The subject may have one or more mutations or deletions in the DNA polymerase γ gene (POLG).
Owner:PRETZEL THERAPEUTICS INC

Methods of treatment for mitochondrial DNA depletion disorders

PCT designated stageWO2026151802A1Mitochondrial depletionPsychiatry
Provided are methods of treating a subject having a Primary Mitochondrial Disorder (PMD) or Mitochondrial DNA Depletion Syndrome (MDDS) comprising administering a therapeutically effective amount of a compound listed in Table 1, Table 2, Table 3, Table 4, or Table 5, wherein the subject does not have a mutation in the DNA polymerase γ gene (POLG).
Owner:PRETZEL THERAPEUTICS INC

Fluorescent quantitative PCR (Polymerase Chain Reaction) primer group and detection kit for detecting herpesvirus type 2 and application of fluorescent quantitative PCR primer group and detection kit

The invention discloses a fluorescent quantitative PCR (Polymerase Chain Reaction) primer group and a detection kit for detecting type-2 agama herpesvirus and application of the fluorescent quantitative PCR primer group and the detection kit. According to the invention, a pair of specific primers IghV2-F and IghV2-R are designed for a gene conserved region of DNA-dependent DNA polymerase (pol) of iamyl herpesvirus type 2 (IghV2), and an SYBR Green dye fluorescent quantitative PCR detection method is established, so that the primer has the advantages of high sensitivity, high specificity, wide linear range, rapidness, simplicity, convenience, good repeatability and the like. The invention provides important technical support for herpesvirus infection monitoring, quarantine and protection work of rare and endangered lizard species, fills the blank of detection methods in the field, and is suitable for non-clinical medical fields such as scientific research, epidemiological investigation, quarantine monitoring, protection management and the like.
Owner:FOSHAN UNIVERSITY

Long oligo synthesis

PendingUS20260015380A1Sugar derivativesSugar derivatives preparationNucleotideOligonucleotide synthesis
Solid supports and methods using the solid supports for de novo long oligo synthesis are disclosed. Long oligos with more than 100 nucleotides are notably difficult to synthesize. The challenges include low percentage yield, high error rate, and difficulty to isolate the correct sequence. Using the disclosed solid supports and their associated methods, oligos with more than 1,000 nucleotides can be readily obtained. The synthesis of the 1,728-nucleotide Φ29 DNA polymerase gene was demonstrated.
Owner:FANG SHIYUE

Construction method of recombinant escherichia coli for efficiently synthesizing pterostilbene

The invention discloses a construction method of recombinant escherichia coli for efficiently synthesizing pterostilbene, and belongs to the technical field of biology. The method comprises the following steps: firstly, inserting an RNAP polymerase gene segment into a safe site SS9 of an escherichia coli genome, then integrating a dCas9 gene into a ycdn site of a recombinant bacterium, then transferring into a FabF-sgRNA plasmid or / and a fumC-sgRNA plasmid, dynamically regulating the malonyl-CoA level, and constructing a pathway for synthesizing pterostilbene from L-tyrosine, thereby obtaining the pterostilbene. By using a co-localization strategy of the enzyme, the accumulation of intermediate metabolites is further reduced, the catalytic efficiency of the enzyme is improved, the yield of the escherichia coli for synthesizing the pterostilbene from the glycerol is improved, the concentration of other byproducts is obviously reduced, and the method has a very good application prospect.
Owner:DALIAN UNIV OF TECH